Did COVID Actually Come From a LAB?
Checked by an AI model against live web sources — how this works · report an error
Who said what, and about what
A bounded sample, most disputed claims first — the full list is belowEvery row is reachable by scrolling its column · search matches claim text, verdicts, people, topics and sources · hover a row to trace its chain, click one to pin its detail
Every claim, checked
No claims match the selected verdicts.
-
Claim 1
“When you entered the Biden White House, you believe that CO 19 came from almost surely a natural outbreak. You now believe it is quote more likely to have been a lab leak.”
Ashish Jha initially considered COVID-19's origin almost certainly natural but later came to regard a laboratory leak as more likely.
CNN reported that Jha entered the White House in April 2022 believing COVID was almost surely natural and later said he thought a lab leak was probably more likely, while emphasizing that the origin remained uncertain.
Sources
- 1CNN transcript: Ashish Jha discusses COVID-19 origins↗
Supports
you went into the White House in April of 2022 thinking that COVID was almost surely naturally was surely natural. And now, you've come out over the weekend and this made a lot of headlines as well, saying that you think that it was a lab link.
- 2CNN transcript: Ashish Jha discusses COVID-19 origins↗
Supports
The circumstantial evidence behind a lab leak got stronger and stronger over time. I was in on a lot of briefings and walking out of those, I thought, boy, it's probably a lab leak.
- 1CNN transcript: Ashish Jha discusses COVID-19 origins↗
-
Claim 2
“Evidence sits inside the lab and the Chinese government has not been forthcoming on it.”
Evidence relevant to the laboratory-origin hypothesis is held inside Chinese laboratories, and the Chinese government has not provided all requested information.
WHO's 2025 SAGO assessment says information about Wuhan laboratory work, staff health records, and biosafety practices was not made available, preventing a complete assessment of a research-related incident.
Sources
- 1WHO SAGO Independent Assessment of the Origins of SARS-CoV-2↗
Supports
Much of the information needed to assess hypothesis #2, of an accidental laboratory related event, either during field investigations or a breach in laboratory biosafety or biosecurity, has not been made available to WHO or SAGO.
- 2WHO SAGO Independent Assessment of the Origins of SARS-CoV-2↗
Supports
WHO has made several requests to the Government of China to provide health records of staff and documentation on biosafety and biosecurity practices and procedures in laboratories in Wuhan, including the Wuhan Institute of Virology (WIV) and the Chinese Centers for Disease Control in Wuhan.
- 1WHO SAGO Independent Assessment of the Origins of SARS-CoV-2↗
-
Claim 3
“But the weight of the evidence in the scientific community is still with zunosis.”
The available scientific evidence still favors a zoonotic origin over a laboratory-related origin.
WHO's SAGO concluded that a zoonotic origin with animal-to-human spillover was the best-supported hypothesis based on available scientific data, although it said the origin remained inconclusive.
Sources
- 1WHO SAGO Independent Assessment of the Origins of SARS-CoV-2↗
Supports
while most available and accessible published scientific evidence supports hypothesis #1, zoonotic transmission from animals, possibly from bats or an intermediate host to humans
- 2WHO SAGO Independent Assessment of the Origins of SARS-CoV-2↗
Supports
a zoonotic origin with spillover from animals to humans is currently considered the best supported hypothesis by the available scientific data
- 1WHO SAGO Independent Assessment of the Origins of SARS-CoV-2↗
-
Claim 4
“We had Ran Paul and other right-wingers start retweeting a debunked figure that claims 82% of women who got the COVID 19 vaccine during the first trimester suffer from miscarriages.”
A figure claiming that 82% of women vaccinated against COVID-19 during the first trimester miscarried was false.
The 82% figure resulted from using an inappropriate denominator and incomplete follow-up. Subsequent CDC and NEJM analyses found no increased miscarriage risk associated with mRNA COVID-19 vaccination in early pregnancy.
Sources
- 1Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons↗
Refutes
No denominator was available to calculate a risk estimate for spontaneous abortions, because at the time of this report, follow-up through 20 weeks was not yet available for 905 of the 1224 participants vaccinated within 30 days before the first day of the last menstrual period or in the first trimester.
- 2On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons↗
Refutes
We agree that the denominator used in that proportion — 827 completed pregnancies — is not an appropriate denominator for the calculation of a risk estimate or rate.
- 3COVID-19 Vaccines While Pregnant or Breastfeeding↗
Refutes
Scientists have not found an increased risk for miscarriage among pregnant people who received an mRNA COVID-19 vaccine just before or during early pregnancy (before 20 weeks of pregnancy).
- 1Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons↗
-
Claim 5
“Republicans are back at it with their ridiculous prosecute Fouchy crusade, releasing his old text messages with little to no context, ridiculously accusing him of covering up crucial information during the CO9 pandemic, and holding him in contempt when he refused to answer their bad faith questions.”
A Republican-led Senate committee voted to hold Anthony Fauci in contempt after he declined to answer questions under subpoena.
The Senate Homeland Security and Governmental Affairs Committee, chaired by Republican Rand Paul, advanced a contempt resolution after Fauci refused to answer questions under subpoena and invoked the Fifth Amendment.
The verdict assesses the factual core that Republicans voted to hold Fauci in contempt after he declined to answer questions; it does not assess the transcript's subjective descriptions such as "ridiculous" or "bad faith."
Sources
- 1Chairman Paul's Contempt Resolution Against Anthony Fauci Advances Out of Committee↗
Supports
Republicans in Senate Homeland Security and Governmental Affairs Committee, under Chairman Rand Paul (R-KY), voted to pass Chairman Paul’s resolution to hold Dr.Anthony Fauci in contempt of Congress for refusing to answer questions under subpoena.
- 2Senate panel votes to hold Fauci in contempt over refusal to answer COVID-19 questions↗
Supports
The vote approving the contempt resolution came a week after Fauci invoked his Fifth Amendment right against self-incrimination more than 100 times when he appeared before the Senate Committee on Homeland Security and Governmental Affairs.
- 1Chairman Paul's Contempt Resolution Against Anthony Fauci Advances Out of Committee↗
-
Claim 6
“who have pointed to the large amount of scientific evidence that says the CO 19 virus most likely came from a zunotic spillover, meaning it originated from an animal.”
The available scientific evidence cited by experts supports a zoonotic spillover origin for COVID-19.
WHO's SAGO assessment states that most available published scientific evidence supports animal-to-human zoonotic transmission and calls it the best-supported hypothesis, while noting that the exact spillover event has not been identified.
Sources
- 1WHO SAGO Independent Assessment of the Origins of SARS-CoV-2↗
Supports
while most available and accessible published scientific evidence supports hypothesis #1, zoonotic transmission from animals, possibly from bats or an intermediate host to humans
- 2WHO SAGO Independent Assessment of the Origins of SARS-CoV-2↗
Supports
a zoonotic origin with spillover from animals to humans is currently considered the best supported hypothesis by the available scientific data
- 1WHO SAGO Independent Assessment of the Origins of SARS-CoV-2↗
-
Claim 7
“Even though there is no hard scientific evidence to support that claim, it's mostly circumstantial.”
The laboratory-leak hypothesis lacks direct hard scientific evidence and relies substantially on circumstantial evidence.
The term "hard scientific evidence" has no agreed operational definition, so the claim cannot be judged exactly as stated. Available assessments do say that no direct evidence of a laboratory incident has been found and that the evidence is incomplete, but some intelligence agencies nevertheless assess a laboratory-associated incident as more likely.
Checked twice, independently: the first pass returned Accurate and the second Unverifiable. Recorded as Unverifiable.
Sources
- 1WHO SAGO Independent Assessment of the Origins of SARS-CoV-2↗
Supports
The reports highlight periodic potential biocontainment and personnel security weaknesses at the WIV that could potentially result in biocontainment breaches; however, the reports do not provide any direct evidence.
- 2Updated Assessment on COVID-19 Origins↗
Background
After examining all available intelligence reporting and other information, though, the IC remains divided on the most likely origin of COVID-19.
- 1WHO SAGO Independent Assessment of the Origins of SARS-CoV-2↗
-
Claim 8
“over 60% of Americans still believe that CO 19 came from a lab.”
More than 60% of Americans in at least one recent national poll believed COVID-19 originated in a laboratory.
A Deseret News/HarrisX poll reported that 69% of American voters said SARS-CoV-2 came from a lab, exceeding 60%. This is a measure of public belief, not evidence that the laboratory-origin hypothesis is correct.
Sources
- 1Did COVID-19 come from a lab or a wet market? Americans weigh in↗
Supports
When asked what theory they support, 69% of American voters said SARS-CoV-2 came from a lab, while only 31% said it emerged naturally, according to the latest Deseret News/HarrisX poll.
- 1Did COVID-19 come from a lab or a wet market? Americans weigh in↗
-
Claim 9
“Dr. Angela Rasmmerson is a leading viologist who has co-authored several studies that indicate co 19 had a natural or zunotic origin.”
Angela Rasmussen is a virologist who coauthored research supporting a natural or zoonotic origin for COVID-19.
The University of Saskatchewan identifies Rasmussen as a virologist, and its account of the Huanan-market research identifies her as a member of the team that published a study linking the pandemic's early epicenter to the market and wildlife sales.
Sources
- 1Angela Rasmussen - University of Saskatchewan College of Medicine↗
Supports
Angela (Angie) Rasmussen, PhD is a virologist at the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan.
- 2Huanan market identified as epicentre of COVID-19 pandemic - University of Saskatchewan↗
Supports
Angela Rasmussen (PhD) brings her expertise in virology to the prairie province as a research scientist. ... was part of the international team that published the study
- 1Angela Rasmussen - University of Saskatchewan College of Medicine↗
-
Claim 10
“Dr. Ashish Ja is a physician and public health expert who served as President Biden's COVID 19 response coordinator”
Ashish Jha is a physician and public-health expert who served as President Biden's COVID-19 response coordinator.
A White House personnel report lists Jha as coordinator of the COVID-19 response, while NIH and National Academies biographies identify him as a physician and public-health researcher.
Sources
- 1White House Annual Report to Congress on White House Office Personnel, July 1, 2022↗
Supports
JHA, ASHISH K. ... ASSISTANT TO THE PRESIDENT AND COORDINATOR OF THE COVID-19 RESPONSE AND COUNSELOR TO THE PRESIDENT
- 2Science, society and lessons from the COVID-19 pandemic - NIH Clinical Center↗
Supports
As an accomplished physician, health policy researcher and global health advocate, he has contributed his expertise to the public through appearances with local, national and global news outlets.
- 1White House Annual Report to Congress on White House Office Personnel, July 1, 2022↗
-
Claim 11
“analysis indicated that there were two separate spillover events. So whether that came from a lab or whether that came from nature um there were two events where this virus entered the human population and we can tell that through phoggenetics it happened about two weeks apart.”
The analysis indicated that SARS-CoV-2 entered humans through two separate spillover events about two weeks apart.
Pekar et al.'s phylodynamic analysis concluded that the two early viral lineages, A and B, resulted from at least two separate cross-species transmissions, with lineage A introduced within weeks of lineage B. The evidence supports the claim as stated that the analysis indicated two events roughly two weeks apart.
Sources
- 1The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2↗
Supports
Novel phylodynamic rooting methods, coupled with epidemic simulations, indicate that these two lineages were the result of at least two separate cross-species transmission events into humans.
- 2Wuhan market was epicentre of pandemic’s start, studies suggest↗
Supports
A third suggests that the coronavirus SARS-CoV-2 spilled over from animals — possibly those sold at the market — to humans at least twice in November or December 2019.
- 1The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2↗
-
Claim 12
“I think anyways that it's more likely that this emerged in a market uh from live animals exactly like SARS Corona virus 1 did in the markets of Guangha.”
The Huanan market origin can be described as occurring from live animals exactly as SARS-CoV-1 did in Guangzhou markets.
Evidence from the 2003 SARS outbreak linked infection risk and SARS-like viruses to live-animal markets in southern China, including Guangzhou and Shenzhen. However, contemporary CDC research explicitly stated that the reservoir remained unknown, so the phrase “exactly like” creates a stronger and more specific impression than the evidence supports.
Omits: The claim omits that the natural reservoir and precise origin of SARS-CoV-1 were still unknown; evidence implicated live-animal markets and market animals, but did not establish that SARS-CoV-1 emerged exactly in Guangzhou markets in the same demonstrated manner.
Checked twice, independently: the first pass returned Misleading and the second Accurate. Recorded as Misleading.
Sources
- 1Epidemiologic Clues to SARS Origin in China↗
Refutes
The reservoir is still unknown, but SARS-CoV has been isolated from Himalayan palm civets (Paguma larvata), and evidence of infection has been found in a raccoon dog (Nyctereutes procyonoides), a Chinese ferret-badger (Melogale moschata), and humans working at a live animal market in Shenzen municipality.
- 2Epidemiologic Clues to SARS Origin in China↗
Supports
The pattern of the Guangdong epidemic is consistent with the classical process of emergence from an animal reservoir: the initial introduction of the virus into a nonimmune human population followed by the establishment and rapid dissemination of infection.
- 1Epidemiologic Clues to SARS Origin in China↗
-
Claim 13
“the Chinese government has not been forthcoming on it.”
The Chinese government has not been forthcoming with information relevant to evaluating a possible laboratory leak.
WHO has said that China shared some information but not everything requested, including early viral sequences, detailed market-animal information, and information about Wuhan laboratory work and biosafety conditions. That supports the speaker's general characterization of incomplete disclosure.
Sources
- 1WHO Director-General's opening remarks at the media briefing – 27 June 2025↗
Supports
WHO recognizes that China has shared some of this information, but not everything that we have requested.
- 2WHO Director-General's opening remarks at the media briefing – 27 June 2025↗
Supports
Despite our repeated requests, China hasn’t provided hundreds of viral sequences from individuals with COVID-19 early in the pandemic, more detailed information on animals sold at markets in Wuhan, and information on work done and biosafety conditions at laboratories in Wuhan.
- 1WHO Director-General's opening remarks at the media briefing – 27 June 2025↗
-
Claim 14
“We have a lot of lab records that are missing. We have databases that were pulled down.”
Many laboratory records were missing and databases had been taken down.
WHO has documented that requested laboratory information was not provided and that SARS-CoV-2 sequences on GISAID were temporarily restricted. Those facts do not establish that a large quantity of laboratory records was missing in the sense of lost or destroyed, so the wording conflates withholding or restricted access with missing records.
Omits: The available evidence distinguishes between information that was not provided or was inaccessible and records that were actually missing; WHO documented temporary restriction of particular data, not proof that many laboratory records had been lost or destroyed.
Checked twice, independently: the first pass returned Misleading and the second Accurate. Recorded as Misleading.
Sources
- 1WHO Director-General's opening remarks at the media briefing – 27 June 2025↗
Background
Despite our repeated requests, China hasn’t provided hundreds of viral sequences from individuals with COVID-19 early in the pandemic, more detailed information on animals sold at markets in Wuhan, and information on work done and biosafety conditions at laboratories in Wuhan.
- 2SAGO statement on newly released SARS-CoV-2 metagenomics data from China CDC on GISAID↗
Background
Access was restricted shortly after, apparently to allow further data updates by China CDC.
- 1WHO Director-General's opening remarks at the media briefing – 27 June 2025↗
-
Claim 15
“The Chinese government has not cooperated with any of the factf finding missions.”
The Chinese government did not cooperate with any fact-finding missions.
China did not provide all information later requested by WHO and SAGO, but the universal claim that it cooperated with no fact-finding mission is contradicted by the WHO-China Joint Mission and the later WHO-convened origins study, both of which involved Chinese officials and scientists.
The intensifier “any” was judged literally: one documented cooperative mission is sufficient to falsify the universal claim.
Sources
- 1WHO-convened global study of origins of SARS-CoV-2: China Part↗
Refutes
Joint WHO-China study: 14 January - 10 February 2021
- 2Press briefing by the international team studying the origins of the COVID-19 virus – 30 March 2021↗
Refutes
There would never have been anything like that if we did not have a very strong and good collaboration with our colleagues in China.
- 1WHO-convened global study of origins of SARS-CoV-2: China Part↗
-
Claim 16
“viology lab that was working on SARS corona viruses had been for for some period of time.”
The Wuhan Institute of Virology was a virology laboratory that had worked on SARS-related coronaviruses for some time.
Publications by researchers affiliated with the Wuhan Institute of Virology document work on bat SARS-related coronaviruses, including research published before the COVID-19 outbreak.
Sources
- 1Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus↗
Supports
A large number of SARS-related coronaviruses (SARSr-CoV) have been detected in horseshoe bats since 2005 in different areas of China.
- 2Potential Links Between the Wuhan Institute of Virology and the Origin of COVID-19↗
Supports
WIV officials including Shi Zhengli—who leads the WIV laboratory group that conducts coronavirus research—stated lab employee samples all tested negative for SARS-CoV-2 antibodies.
- 1Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus↗
-
Claim 17
“The bats that that harbor these viruses live thousands of kilometers away.”
The bats harboring related coronaviruses live thousands of kilometers from Wuhan.
The closest known SARS-CoV-2-related viral precursors have been identified in horseshoe bats in southern China and Laos, locations substantially distant from Wuhan; the statement is broadly consistent with those sampling locations.
Sources
- 1Independent assessment of the origins of SARS-CoV-2↗
Supports
Closest precursors identified to date were in bats in China and Lao PDR
- 2Bat coronaviruses related to SARS-CoV-2 and infectious for human cells↗
Background
The animal reservoir of SARS-CoV-2 is unknown despite reports of SARS-CoV-2-related viruses in Asian Rhinolophus bats
- 1Independent assessment of the origins of SARS-CoV-2↗
-
Claim 18
“there is a very big coincidence here that it happens to be that the first version of this virus out in the community is in the community where this v this um uh where this lab is.”
The first detected community cluster of SARS-CoV-2 was in Wuhan, where the relevant laboratory was located.
The first confirmed cluster of COVID-19 cases arose in Wuhan, and the Wuhan Institute of Virology is located there. However, official assessments distinguish the first confirmed cluster from the location of the very first infection.
The phrase "first version of this virus out in the community" is judged as referring to the first confirmed cluster, not the first infection. The location of the first infection remains unknown.
Sources
- 1Updated Assessment on COVID-19 Origins↗
Supports
We assess that the first cluster of confirmed COVID-19 cases arose in Wuhan, China, in late 2019, but we lack insight—and may never have it—on where the first SARS-CoV-2 infection occurred.
- 1Updated Assessment on COVID-19 Origins↗
-
Claim 19
“I have increasingly come to conclude it was a super spreader event that maybe somebody got there and then spread it to a lot of people.”
The Huanan market may have been an early superspreading or amplification event.
Scientific reviews and WHO assessments support the possibility that the Huanan Seafood Market played an important amplification or early superspreading role, while not establishing that it was the original spillover site.
Sources
- 1SAGO Preliminary Report↗
Supports
Early human samples showed that the SARS-CoV-2 virus strains from some of the cases linked to the Huanan market were identical or highly similar, suggesting the market may have been the source of an amplification event.
- 2The emergence, genomic diversity and global spread of SARS-CoV-2↗
Supports
Therefore, although it has not been resolved fully, the current evidence suggests that the Huanan Seafood Market could be the location of an early ‘superspreading’ event.
- 1SAGO Preliminary Report↗
-
Claim 20
“we don't have it definitively but there are a lot of things pointing to a lab leak”
There is no definitive evidence establishing either a laboratory incident or zoonotic spillover as the origin of SARS-CoV-2.
WHO and U.S. intelligence assessments continue to describe major evidence gaps and do not regard either hypothesis as conclusively established, although available evidence is weighted differently by different institutions.
Sources
- 1WHO Scientific advisory group issues report on origins of COVID-19↗
Supports
The work to understand the origins of SARS-CoV-2 remains unfinished.
- 2Updated Assessment on COVID-19 Origins↗
Supports
We assess that the first cluster of confirmed COVID-19 cases arose in Wuhan, China, in late 2019, but we lack insight—and may never have it—on where the first SARS-CoV-2 infection occurred.
- 1WHO Scientific advisory group issues report on origins of COVID-19↗
-
Claim 21
“the weight of available evidence suggests zunotic spillover either directly from bats or through an immed intermediate host.”
WHO's scientific advisory group said the weight of available evidence suggests zoonotic spillover, directly from bats or through an intermediate host.
This accurately quotes the conclusion reported by WHO's Scientific Advisory Group for the Origins of Novel Pathogens in its 2025 assessment.
Sources
- 1WHO Scientific advisory group issues report on origins of COVID-19↗
Supports
In its report, SAGO considered available evidence for the main hypotheses for the origins of COVID-19 and concluded that “the weight of available evidence…suggests zoonotic spillover…either directly from bats or through an intermediate host.”
- 1WHO Scientific advisory group issues report on origins of COVID-19↗
-
Claim 22
“did you have access to lab data and lab records? They did not. Did you were you able to interview lab workers? you were not.”
WHO did not receive the laboratory data, records, and additional staff interviews needed to independently evaluate a possible laboratory incident.
SAGO reported that it lacked independent access to key laboratory records and that requests for further documentation and interviews with WIV and Wuhan CDC staff were refused. But WHO's earlier joint mission did obtain verbal assurances from WIV representatives, so the absolute claim that WHO had no access or no interviews at all overstates the record.
Omits: The statement omits that the 2021 WHO-China mission received verbal assurances from WIV representatives and that the more precise finding is that independent access to occupational-health records, audits, biosafety documentation, and further staff interviews was not provided.
The absolute wording "They did not" and "you were not" is judged as referring to all WHO work, whereas the evidence specifically supports a lack of independent access to requested records and further interviews for SAGO.
Sources
- 1Scientific Advisory Group for the Origins of Novel Pathogens: Independent assessment of the origins of SARS-CoV-2↗
Background
Representatives of the WIV laboratory provided verbal assurances that appropriate procedures were and are being followed correctly, although no physical inspections were done by the WHO-China international team in 2021 (WHO, 2021).
- 2Scientific Advisory Group for the Origins of Novel Pathogens: Independent assessment of the origins of SARS-CoV-2↗
Supports
WHO Secretariat wrote to the Government of China to request further investigations, audits and other relevant documentation and interviews with staff at the WIV and Wuhan CDC laboratory. However, this has been refused, no audit files have been made available for review
- 1Scientific Advisory Group for the Origins of Novel Pathogens: Independent assessment of the origins of SARS-CoV-2↗
-
Claim 23
“much of the information needed to assess hypothesis number two of an accidental laboratory related event either during field investigations or a breach in laboratory biosafety or biocurity has not been made available to WHO or the scientific advisory group.”
The WHO report acknowledged that much information needed to assess a laboratory-related event had not been made available to WHO or SAGO.
The quoted statement accurately reflects the report's conclusion that important information needed to evaluate a laboratory-related hypothesis had not been provided.
Sources
- 1WHO Scientific advisory group issues report on origins of COVID-19↗
Supports
SAGO has advanced the understanding of the origins of COVID-19, but as they say in their report, much of the information needed to evaluate fully all hypotheses has not been provided.
- 2Scientific Advisory Group for the Origins of Novel Pathogens: Independent assessment of the origins of SARS-CoV-2↗
Supports
Since information needed to assess the hypothesis of a lab related event, either during field investigations or a breach in laboratory biosafety - has not been made available to WHO or SAGO, it was not possible for SAGO to evaluate this hypothesis.
- 1WHO Scientific advisory group issues report on origins of COVID-19↗
-
Claim 24
“of the agencies uh seem to believe that it came from the Wuhan Institute of Irology.”
Multiple U.S. agencies appear to believe that COVID-19 originated at the Wuhan Institute of Virology.
The U.S. intelligence community was divided, but the public ODNI assessment did not say that multiple agencies specifically concluded the virus originated at WIV. It said one agency favored a laboratory incident probably involving WIV, while DOE and FBI favored a laboratory-associated incident for different reasons.
Omits: The publicly released intelligence assessment identifies one agency as attributing the first infection probably to a laboratory incident involving the Wuhan Institute of Virology; it does not publicly establish that multiple agencies specifically concluded the virus came from WIV.
Checked twice, independently: the first pass returned Misleading and the second Accurate. Recorded as Misleading.
Sources
- 1Potential Links Between the Wuhan Institute of Virology and the Origin of the COVID-19 Pandemic↗
Background
The Central Intelligence Agency and another agency remain unable to determine the precise origin of the COVID-19 pandemic, as both hypotheses rely on significant assumptions or face challenges with conflicting reporting.
- 2Independent assessment of the origins of SARS-CoV-2↗
Refutes
One element assesses with moderate confidence that the first human infection with SARS-CoV-2 most likely was the result of a laboratory-associated incident, probably involving experimentation, animal handling, or sampling by the Wuhan Institute of Virology.
- 1Potential Links Between the Wuhan Institute of Virology and the Origin of the COVID-19 Pandemic↗
-
Claim 25
“the department of energy has assessed that it c came from the Wuhan CDC”
The Department of Energy assessed that COVID-19 came specifically from the Wuhan CDC.
Publicly released U.S. assessments state only that DOE judged a laboratory-associated incident most likely; they do not publicly identify the Wuhan CDC as the source. Because DOE's underlying intelligence remains classified, the more specific attribution cannot be confirmed or refuted from available evidence.
Checked twice, independently: the first pass returned Unverifiable and the second Misleading. Recorded as Unverifiable.
Sources
- 1Potential Links Between the Wuhan Institute of Virology and the Origin of the COVID-19 Pandemic↗
Background
The Department of Energy and the Federal Bureau of Investigation assess that a laboratory-associated incident was the most likely cause of the first human infection with SARS-CoV-2, although for different reasons.
- 2Potential Links Between the Wuhan Institute of Virology and the Origin of the COVID-19 Pandemic↗
Background
This report does not address the merits of the two most likely pandemic origins hypotheses, nor does it explore other biological facilities in Wuhan other than the WIV.
- 1Potential Links Between the Wuhan Institute of Virology and the Origin of the COVID-19 Pandemic↗
-
Claim 26
“either that's in a bat in nature or it's in a freezer in a lab. Um, we haven't found it in either one.”
A progenitor virus has not been found either in nature or in a laboratory freezer.
No immediate or close progenitor of SARS-CoV-2 has been identified in sampled bats or publicly documented as being held in a Wuhan laboratory. The ODNI report also says it found no known WIV virus that could plausibly be a progenitor.
Sources
- 1Bat coronaviruses related to SARS-CoV-2 and infectious for human cells↗
Supports
SARS-CoV-2 progenitor bat viruses genetically close to SARS-CoV-2 and able to enter human cells through a human ACE2 (hACE2) pathway have not yet been identified, although they would be key in understanding the origin of the epidemic.
- 2Potential Links Between the Wuhan Institute of Virology and the Origin of the COVID-19 Pandemic↗
Supports
Information available to the IC indicates that some of the research conducted by the PLA and WIV included work with several viruses, including coronaviruses, but no known viruses that could plausibly be a progenitor of SARS-CoV-2.
- 1Bat coronaviruses related to SARS-CoV-2 and infectious for human cells↗
-
Claim 27
“We have found however viruses that are very closely related in these bats in Laos.”
Very closely related SARS-CoV-2-like viruses have been found in bats in Laos.
Researchers identified SARS-CoV-2-related sarbecoviruses in cave bats in northern Laos. These viruses are among the closest known relatives of SARS-CoV-2, although they are not the progenitor virus itself.
Sources
- 1Bat coronaviruses related to SARS-CoV-2 and infectious for human cells↗
Supports
Here we show that such viruses circulate in cave bats living in the limestone karstic terrain in northern Laos, in the Indochinese peninsula.
- 2Bat coronaviruses related to SARS-CoV-2 and infectious for human cells↗
Supports
Our findings therefore indicate that bat-borne SARS-CoV-2-like viruses that are potentially infectious for humans circulate in Rhinolophus spp. in the Indochinese peninsula.
- 1Bat coronaviruses related to SARS-CoV-2 and infectious for human cells↗
-
Claim 28
“we have this cluster of samples in the corner where the animals were sold.”
There is a cluster of SARS-CoV-2-positive market samples in the area where animals were sold.
Analyses of Huanan market sampling found a positivity hotspot near wildlife stalls and detected SARS-CoV-2 together with genetic material from susceptible wildlife. This supports the stated spatial association, but does not by itself prove that an infected animal transmitted the virus to humans.
Sources
- 1What we can and cannot learn from SARS-CoV-2 and animals in metagenomic samples from the Huanan market↗
Supports
The details published by Liu et al. (2023b) on the numbers of samples collected in each stall, and the associated PCR and sequencing results, allowed the identification of a positivity hotspot in the market, controlling for sampling effort.
- 2What we can and cannot learn from SARS-CoV-2 and animals in metagenomic samples from the Huanan market↗
Supports
If the virus comes from infected animals, then there should exist stalls in which the genetic materials of SARS-CoV-2 and of susceptible animals are detectable together.
- 1What we can and cannot learn from SARS-CoV-2 and animals in metagenomic samples from the Huanan market↗
-
Claim 29
“the weight of the evidence in the scientific community is still with zunosis the WHO report I mentioned went through all the evidence said the bulk is with that”
The weight of evidence in the scientific community favors a zoonotic origin, and the WHO report said the bulk of the evidence supported it.
WHO's SAGO assessment states that the weight of available evidence suggests zoonotic spillover, while emphasizing that the precise spillover event and location remain uncertain. Thus the claim about the evidentiary balance is supported, but it should not be read as saying the origin has been conclusively established.
The intensifier "the weight of the evidence" was judged as meaning the balance of currently reviewed evidence, not a unanimous scientific consensus. The WHO assessment explicitly says the evidence favors zoonotic spillover while also saying certainty is unavailable.
Sources
- 1Independent assessment of the origins of SARS-CoV-2↗
Supports
The weight of available evidence reviewed by SAGO suggests zoonotic spillover of SARS-CoV-2 into the human population, either directly from bats or through an intermediate host.
- 2Independent assessment of the origins of SARS-CoV-2↗
Background
However, SAGO cannot conclude with certainty where and when this occurred, nor if the HSM was indeed the first instance of spillover into the human population, or the site of further spillover and amplification.
- 1Independent assessment of the origins of SARS-CoV-2↗
-
Claim 30
“a bunch of other agencies, four other unnamed US intelligence agencies say, "No, it came from an animal."”
Four other unnamed U.S. intelligence agencies assessed that the virus came from an animal.
The underlying count is broadly consistent with the declassified assessment, which says four IC elements and the National Intelligence Council favored natural exposure. However, the transcript removes the crucial low-confidence qualifier and simplifies the assessment into a definite conclusion that it came from an animal.
Omits: The four intelligence elements assessed the natural-exposure hypothesis only with low confidence, and their formulation included an animal infected with SARS-CoV-2 or a close progenitor virus; they did not state that an animal origin was definitively established.
Checked twice, independently: the first pass returned Accurate and the second Misleading. Recorded as Misleading.
Sources
- 1Updated Assessment on COVID-19 Origins↗
Background
Four IC elements and the National Intelligence Council assess with low confidence that the initial SARS-CoV-2 infection was most likely caused by natural exposure to an animal infected with it or a close progenitor virus—a virus that probably would be more than 99 percent similar to SARS-CoV-2.
- 1Updated Assessment on COVID-19 Origins↗
-
Claim 31
“the science is split.”
There is significant scientific disagreement about the origins of COVID-19.
“Science” has no agreed operational definition here, and the claim does not specify whether it refers to published studies, individual scientists, scientific institutions, or the evidentiary balance. The available record includes both a WHO assessment favoring zoonotic spillover and continuing disagreement over the laboratory-origin hypothesis, so the claim as worded cannot be cleanly adjudicated.
Checked twice, independently: the first pass returned Accurate and the second Unverifiable. Recorded as Unverifiable.
Sources
- 1WHO Scientific advisory group issues report on origins of COVID-19↗
Background
the weight of available evidence…suggests zoonotic spillover…either directly from bats or through an intermediate host.
- 2Updated Assessment on COVID-19 Origins↗
Background
the IC remains divided on the most likely origin of COVID-19.
- 1WHO Scientific advisory group issues report on origins of COVID-19↗
-
Claim 32
“Oh, the intelligence agencies say it's a lab leak.”
Some intelligence agencies assess a laboratory-associated origin as most likely, while others favor natural exposure or cannot determine the origin.
The intelligence community is divided, but the transcript's wording suggests that intelligence agencies generally say it was a lab leak. The declassified assessment instead reports a mixed set of conclusions, including agencies that favor natural exposure and agencies that remain unable to determine the origin.
Omits: The claim leaves out that the U.S. Intelligence Community says all agencies consider both hypotheses plausible; four agencies and the National Intelligence Council favor natural exposure, two favor a laboratory-associated incident, and two cannot determine the origin.
Checked twice, independently: the first pass returned Misleading and the second Accurate. Recorded as Misleading.
Sources
- 1Report on Potential Links Between the Wuhan Institute of Virology and the Origins of COVID-19↗
Refutes
All agencies continue to assess that both a natural and laboratory-associated origin remain plausible hypotheses to explain the first human infection.
- 2Report on Potential Links Between the Wuhan Institute of Virology and the Origins of COVID-19↗
Refutes
The National Intelligence Council and four other IC agencies assess that the initial human infection with SARS-CoV-2 most likely was caused by natural exposure to an infected animal
- 3Report on Potential Links Between the Wuhan Institute of Virology and the Origins of COVID-19↗
Supports
The Department of Energy and the Federal Bureau of Investigation assess that a laboratory-associated incident was the most likely cause of the first human infection with SARS-CoV-2
- 1Report on Potential Links Between the Wuhan Institute of Virology and the Origins of COVID-19↗
-
Claim 33
“scientific evidence is only going to be available on one side because any evidence on the other side is going to have to come from cooperation with the Chinese government.”
Scientific evidence is available mainly for the natural-origin hypothesis because evidence relevant to a laboratory origin depends on Chinese government cooperation.
China has withheld or failed to provide important data needed to evaluate the laboratory hypothesis, but it is inaccurate to say evidence exists only on the natural-origin side. The available record contains evidence and assessments relevant to both hypotheses, with major gaps remaining for the lab-associated hypothesis.
Omits: The claim omits that evidence relevant to a laboratory-associated origin already exists, including intelligence reporting, information about Wuhan Institute of Virology research and biosafety, and records of researcher illnesses, although important Chinese data remain unavailable.
Sources
- 1Report on Potential Links Between the Wuhan Institute of Virology and the Origins of COVID-19↗
Refutes
This report outlines the IC’s understanding of the WIV, its capabilities, and the actions of its personnel leading up to and in the early days of the COVID-19 pandemic.
- 2WHO Scientific advisory group issues report on origins of COVID-19↗
Supports
much of the information needed to evaluate fully all hypotheses has not been provided.
- 3WHO Scientific advisory group issues report on origins of COVID-19↗
Background
The weight of available evidence…suggests zoonotic spillover…either directly from bats or through an intermediate host.
- 1Report on Potential Links Between the Wuhan Institute of Virology and the Origins of COVID-19↗
-
Claim 34
“there's so much uh DNA in or RNA in the in the Hunan market.”
Environmental samples from the Huanan market contained SARS-CoV-2 RNA and DNA from susceptible mammalian wildlife.
Studies of Huanan market environmental samples detected SARS-CoV-2 RNA and DNA from mammalian wildlife species susceptible to SARS-CoV-2. These findings support the factual presence of such genetic material, although they do not by themselves prove that an infected animal transmitted the virus there.
Sources
- 1Genetic tracing of market wildlife and viruses at the epicenter of the COVID-19 pandemic↗
Supports
DNA of mammalian wildlife species susceptible to SARS-CoV-2 was detected along with SARS-CoV-2 and other viruses in environmental samples from animal stalls located at the market epicenter of the emergence of COVID-19.
- 2SARS-CoV-2 infection at the Huanan seafood market↗
Supports
64 environmental samples collected inside the market, mostly from stalls and sewage wells, showed the presence of SARS-CoV-2 RNA.
- 1Genetic tracing of market wildlife and viruses at the epicenter of the COVID-19 pandemic↗
-
Claim 35
“Why have the workers not been made available for interviews?”
Wuhan laboratory workers were not made available for interviews to the WHO investigation.
The WHO-led mission reported interviewing clinical, laboratory, and public-health professionals during its Wuhan visit. China did withhold other important records and data, but the absolute claim that workers were not made available for interviews is contradicted by the mission's account.
Sources
- 1Origins of SARS-CoV-2: window is closing for key scientific studies↗
Refutes
This January, we undertook a 28-day mission to Wuhan to interview clinical, laboratory and public-health professionals and visit institutions involved in the early epidemic response and subsequent investigations.
- 1Origins of SARS-CoV-2: window is closing for key scientific studies↗
-
Claim 36
“Why was the WHO blocked from looking at were there progenitor viruses or not?”
The WHO was denied access to important information needed to determine whether Wuhan laboratories held SARS-CoV-2 progenitor viruses.
WHO says China did not provide information about work done and biosafety conditions at Wuhan laboratories, and later reporting says repeated requests for laboratory records and related data were not fulfilled. The WHO did visit and interview personnel, but lacked key underlying information needed to assess the progenitor-virus question fully.
“Blocked from looking” is judged as being denied the requested underlying records and data, not as being denied every physical visit or conversation with laboratory personnel.
Sources
- 1WHO Scientific advisory group issues report on origins of COVID-19↗
Supports
To date, China has not shared this information either with SAGO or WHO.
- 2COVID’s origins: what we do and don’t know↗
Supports
Repeated requests have been made to the Chinese government by the WHO to release the health records of research-lab staff, biosafety and biosecurity protocols, and audits or independent inspections conducted to verify the safety procedures of labs in Wuhan.
- 1WHO Scientific advisory group issues report on origins of COVID-19↗
-
Claim 37
“there's been a correction on that paper. It doesn't change the conclusions. and even science which is the journal that published that paper their editors agreed that it didn't change the conclusions it changed the baze factor”
A correction to the Science paper on multiple zoonotic origins changed its Bayes-factor treatment but did not change the paper's conclusions.
The published erratum changed the Bayes-factor significance cutoffs and related calculations while explicitly stating that the analysis still supported the conclusion of at least two cross-species transmissions. The erratum itself supports the substantive claim that the authors' stated conclusions were unchanged.
Sources
- 1Erratum for the Research Article “The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2”↗
Supports
Bayes factor significance cutoffs from Kass and Raftery (1995) are now used throughout the text, including Table 1, where the probability of inferred ancestral haplotypes is reported.
- 2Erratum for the Research Article “The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2”↗
Supports
This analysis independently supports the conclusion that lineages A and B were most likely the result of at least two cross-species transmissions of SARS-CoV-2.
- 1Erratum for the Research Article “The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2”↗
-
Claim 38
“Anthony Fouchy is of course under fire from the Republicans in Congress right now for allegedly they say lying about NIH funding of gain of function research at the Wuhan Institute of Biology”
Anthony Fauci was under fire from Republicans in Congress, who alleged that he lied about NIH funding of gain-of-function research at the Wuhan Institute of Virology.
Republican lawmakers publicly accused Fauci of lying about NIH-funded gain-of-function research at the Wuhan Institute of Virology. The transcript’s 'Institute of Biology' appears to be a transcription error for the Wuhan Institute of Virology.
Sources
- 1A Hearing With Dr. Anthony Fauci↗
Supports
Many right-wing figures have since accused Dr. Fauci of lying to Congress with respect to that and similar statements he made in a subsequent Senate hearing.
- 1A Hearing With Dr. Anthony Fauci↗
-
Claim 39
“where scientists were studying bat corona viruses.”
Scientists at the Wuhan Institute of Virology studied naturally occurring bat coronaviruses through an NIH-funded subaward.
NIH states that its grant supported research on naturally occurring bat coronaviruses at the Wuhan Institute of Virology through a subaward to EcoHealth Alliance.
Sources
- 1Statement on Misinformation about SARS-CoV-2 Origins↗
Supports
NIH wants to set the record straight on NIH-supported research to understand naturally occurring bat coronaviruses at the Wuhan Institute of Virology, funded through a subaward from NIH grantee EcoHealth Alliance.
- 1Statement on Misinformation about SARS-CoV-2 Origins↗
-
Claim 40
“And what that said was that it is gain of function research effectively if you make a virus more transmissible and/or more pathogenic or more severe in humans specifically.”
The P3CO framework effectively defined the relevant research as enhancing a virus’s transmissibility and/or pathogenicity or virulence in humans.
The speaker captures the core biological criterion, but presents it as if any experiment that makes a virus more transmissible or severe in humans automatically falls under P3CO. The official framework applies the criterion within a narrower regulatory framework involving reasonably anticipated enhanced potential pandemic pathogens.
Omits: The statement omits the framework’s limiting qualifiers that the research must be reasonably anticipated to create, transfer, or use an enhanced potential pandemic pathogen, and that the enhancement concerns transmissibility and/or virulence in humans.
Sources
- 1Office of Science Policy: Gain-of-Function Research↗
Refutes
ePPP research is research that “may be reasonably anticipated to create, transfer or use potential pandemic pathogens resulting from the enhancement of a pathogen’s transmissibility and/or virulence in humans.”
- 2Global Pandemics: Gain-of-Function Research of Concern↗
Background
In January 2017, OSTP released Recommended Policy Guidance for Departmental Development of Review Mechanisms for Potential Pandemic Pathogen Care and Oversight (P3CO), which described attributes of federal agency review and reporting processes for the additional oversight of federally funded research that would be anticipated to create, transfer, or use enhanced pathogens with pandemic potential.
- 1Office of Science Policy: Gain-of-Function Research↗
-
Claim 41
“under that definition which was the US policy at the time uh those experiments did not fall into that category there's a lot of confusion.”
Under the P3CO regulatory definition in effect at the time, the Wuhan-related experiments did not fall into the category of gain-of-function research subject to that framework.
Under the U.S. government’s operative P3CO classification, NIH and Fauci stated that the Wuhan subaward research did not meet the regulatory definition requiring that designation. The experiments can still be described as gain-of-function under broader scientific usage, but that is not the narrower claim made here.
Sources
- 1A Hearing With Dr. Anthony Fauci↗
Supports
Dr. Fauci. As you said, Congressman Ruiz, according to the regulatory and operative definition of P3CO, the NIH did not fund gain-of-function research at the Wuhan Institute of Virology.
- 2Global Pandemics: Gain-of-Function Research of Concern↗
Supports
In testimony to the House Select Committee on the Coronavirus Pandemic, NIH reportedly concluded that the research project did not meet the criteria of the 2014 pause on GOF research or the 2017 HHS P3CO guidance.
- 3The National Institutes of Health and EcoHealth Alliance Did Not Effectively Monitor Awards and Subawards↗
Background
We recommend that NIH ... assess whether NIAID staff are following policy to err on the side of inclusion when determining whether to refer research that may involve ePPP for further review.
- 1A Hearing With Dr. Anthony Fauci↗
-
Claim 42
“The reason why you would do gain of function research, for example, in this case, uh, this type of work was to look at these corona viruses that were circulating in nature and try to assess which ones were pandemic threats.”
The purpose of this type of work was to examine naturally circulating coronaviruses and assess which ones posed pandemic threats.
The NIH-funded project was designed to study bat coronaviruses, evaluate their zoonotic or pandemic potential, and support preparedness against future coronavirus outbreaks. The cited 2015 study likewise described examining the disease potential of a circulating bat coronavirus.
Sources
- 1Project Grant R01AI110964↗
Supports
This includes providing critical reagents, therapeutic interventions, and viral genome sequences for pandemic and public health preparedness to counter future potential coronavirus outbreaks.
- 2A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence↗
Supports
Here we examine the disease potential of a SARS-like virus, SHC014-CoV, which is currently circulating in Chinese horseshoe bat populations.
- 1Project Grant R01AI110964↗
-
Claim 43
“you put the spike protein for one of these viruses into another virus and then you see if it can infect human cells or a mouse that's expressing the human receptor.”
The experiments included inserting one coronavirus’s spike protein into another viral backbone and testing whether the resulting virus could infect human cells or replicate in mice expressing human receptors.
The published research describes creating a chimeric virus with a bat-coronavirus spike in a SARS-CoV backbone, testing it in primary human airway cells, and evaluating related chimeric viruses in humanized mice. The exact experimental systems varied across studies, but the factual description is supported.
Sources
- 1A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence↗
Supports
Using the SARS-CoV reverse genetics system, we generated and characterized a chimeric virus expressing the spike of bat coronavirus SHC014 in a mouse-adapted SARS-CoV backbone.
- 2A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence↗
Supports
The results indicate that group 2b viruses encoding the SHC014 spike in a wild-type backbone can efficiently use multiple orthologs of the SARS receptor human angiotensin converting enzyme II (ACE2), replicate efficiently in primary human airway cells and achieve in vitro titers equivalent to epidemic strains of SARS-CoV.
- 3Origins of COVID-19: An Examination of Available Evidence↗
Supports
In 2017 to 2018, with NIH funding, the Wuhan Institute of Virology constructed genetically modified SARS viruses that combined the spike gene from one bat SARS virus with the rest of the genetic information from another bat SARS virus, obtaining new viruses that efficiently infected human cells.
- 1A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence↗
-
Claim 44
“they grew more virus, it must be more transmissible. And that's not true”
Greater virus growth in an experiment does not necessarily mean greater transmissibility.
Replication or yield in a particular cell-culture system is not, by itself, a direct measure of transmission between infected hosts. Cell-culture experiments do not capture the tissue, host, behavioral and epidemiological factors that determine transmissibility.
Sources
- 1Host Range, Host–Virus Interactions, and Virus Transmission↗
Supports
Undoubtedly, one of the critical challenges to initiating the viral replication cycle in a host lies with the virus’ ability to overcome multiple barriers as it moves from cell-to-cell to tissue-to-tissue within the host organism and from organism-to-organism, and even across species.
- 2Viral cell-to-cell spread: Conventional and non-conventional ways↗
Supports
Experiments conducted in 2-dimensional cell culture models provide valuable information on the mechanisms of viral spread, but do not take into account how the complexity and environment of the tissue impacts virus spread in vivo.
- 1Host Range, Host–Virus Interactions, and Virus Transmission↗
-
Claim 45
“And the reason they were doing it was to assess pandemic risk. It wasn't to, you know, make deadlier viruses just to do so.”
The purpose of the research was to assess pandemic risk rather than to make viruses deadlier merely for its own sake.
Federal policy documents show that some enhanced-pathogen research was evaluated in terms of pandemic risk and potential benefits, but the transcript does not identify the specific researchers or experiments, and research motives cannot be established from this statement alone.
Sources
- 1Recommended Policy Guidance for Departmental Development of Review Mechanisms for Potential Pandemic Pathogen Care and Oversight↗
Background
The intent of this document is to recommend consistent and appropriate Federal agency review and reporting processes for the enhanced oversight of Federally funded research that is anticipated to create, transfer, or use enhanced pathogens with pandemic potential.
- 2Notice Announcing the Removal of the Funding Pause for Gain-of-Function Research Projects↗
Background
During the funding pause, the U.S. Government undertook a deliberative process to assess the potential benefits and risks associated with these types of studies.
- 1Recommended Policy Guidance for Departmental Development of Review Mechanisms for Potential Pandemic Pathogen Care and Oversight↗
-
Claim 46
“Jay Bachari who's currently head of the NIH. His boss is RFK Jr. the health and human services secretary”
Jay Bhattacharya is the NIH director, and Robert F. Kennedy Jr. is the HHS secretary.
NIH identifies Jayanta “Jay” Bhattacharya as its 18th director, beginning April 1, 2025, and HHS identifies Robert F. Kennedy Jr. as the department’s secretary. The word “boss” is colloquial, but both institutional positions are correctly identified.
Sources
- 1The NIH Director↗
Supports
Jayanta "Jay" Bhattacharya, M.D., Ph.D., took the helm as 18th director of the National Institutes of Health, the nation’s medical research agency, on April 1, 2025.
- 2HHS Leadership↗
Supports
Robert F. Kennedy, Jr. is the 26th Secretary of the U.S. Department of Health and Human Services.
- 1The NIH Director↗
-
Claim 47
“the RSV epidemic that we had as the biggest killer of kids today came from these kind of gain of function experiments.”
RSV came from gain-of-function experiments and was the biggest killer of children at the time described.
The historical record describes RSV as a virus identified from chimpanzees and children in the 1950s, not as a product of gain-of-function experiments. CDC data characterize RSV as a major cause of infant hospitalization, while leading causes of death among U.S. children include accidents, congenital conditions, cancer and suicide.
Sources
- 1Etymologia: Syncytium↗
Refutes
Respiratory syncytial virus was discovered in 1956 by Morris et al., who isolated it from a group of chimpanzees with respiratory symptoms.
- 2About RSV↗
Refutes
Respiratory syncytial virus (RSV) usually causes mild, cold-like symptoms in most people, but it is the leading cause of infant hospitalization in the U.S.
- 3RFK Jr.'s Falsehood-Filled CNN Interview↗
Refutes
In 2021, Children’s Health Defense, the nonprofit Kennedy founded and formerly chaired that misleads about vaccination, published an article claiming that RSV came from chimpanzees in a lab being used for vaccine research and development, although it did not describe any gain-of-function research.
- 1Etymologia: Syncytium↗
-
Claim 48
“Lyme disease almost certainly came from this type of research.”
Lyme disease almost certainly came from gain-of-function research.
Available evidence places the Lyme disease bacterium in North America tens of thousands of years ago, long before modern gain-of-function research. The claim therefore conflicts with the established evolutionary history of Borrelia burgdorferi.
Sources
- 1Ancient History of Lyme Disease in North America Revealed with Bacterial Genomes↗
Refutes
A team of researchers led by the Yale School of Public Health has found that the Lyme disease bacterium is ancient in North America, circulating silently in forests for at least 60,000 years—long before the disease was first described in Lyme, Connecticut, in 1976 and long before the arrival of humans.
- 2Genomic insights into the ancient spread of Lyme disease across North America↗
Refutes
Finally, we find B. burgdorferi diversity is ancient (~ 60,000 years old), predating the recent Lyme disease epidemic of the last ~40 years, as well as the Last Glacial Maximum ~20,000 years ago.
- 1Ancient History of Lyme Disease in North America Revealed with Bacterial Genomes↗
-
Claim 49
“What's the oldest record of Lyme disease? Like 60,000 years or something.”
The oldest record of Lyme disease is approximately 60,000 years old.
Researchers estimate that B. burgdorferi lineages in North America are about 60,000 years old, but this is not an ancient medical record diagnosing Lyme disease. The statement conflates evolutionary dating of the pathogen with a historical record of human disease.
Omits: The approximately 60,000-year estimate refers to the inferred age and diversity of the Lyme disease bacterium, Borrelia burgdorferi, based on genomic analysis—not to a documented clinical record of Lyme disease in a person.
Checked twice, independently: the first pass returned Misleading and the second False. Recorded as Misleading.
Sources
- 1Genomic insights into the ancient spread of Lyme disease across North America↗
Background
Finally, we find B. burgdorferi diversity is ancient (~ 60,000 years old), predating the recent Lyme disease epidemic of the last ~40 years, as well as the Last Glacial Maximum ~20,000 years ago.
- 2Ancient History of Lyme Disease in North America Revealed with Bacterial Genomes↗
Background
The tree was far older than the team had expected—at least 60,000 years old.
- 1Genomic insights into the ancient spread of Lyme disease across North America↗
-
Claim 50
“No RSV did not come from a lab.”
RSV did not come from a laboratory.
The documented history of RSV traces its identification to naturally occurring respiratory illness in chimpanzees and children in the 1950s, with no evidence that it was created in a laboratory. The available record supports the speaker’s categorical denial in this context.
Sources
- 1Etymologia: Syncytium↗
Supports
Respiratory syncytial virus was discovered in 1956 by Morris et al., who isolated it from a group of chimpanzees with respiratory symptoms.
- 2The Story behind the Science: On the discovery of respiratory syncytial virus↗
Supports
Researchers soon thereafter identified the same virus in children with pneumonia.
- 1Etymologia: Syncytium↗
-
Claim 51
“No Lyme disease did not come from a lab.”
Lyme disease did not come from a laboratory.
Genomic evidence indicates that the Lyme disease bacterium was circulating in North America for at least 60,000 years, long before modern laboratory research. This supports the statement that Lyme disease was not introduced by a laboratory experiment.
Sources
- 1Ancient History of Lyme Disease in North America Revealed with Bacterial Genomes↗
Supports
A team of researchers led by the Yale School of Public Health has found that the Lyme disease bacterium is ancient in North America, circulating silently in forests for at least 60,000 years—long before the disease was first described in Lyme, Connecticut, in 1976 and long before the arrival of humans.
- 2Genomic insights into the ancient spread of Lyme disease across North America↗
Supports
Finally, we find B. burgdorferi diversity is ancient (~ 60,000 years old), predating the recent Lyme disease epidemic of the last ~40 years, as well as the Last Glacial Maximum ~20,000 years ago.
- 1Ancient History of Lyme Disease in North America Revealed with Bacterial Genomes↗
-
Claim 52
“my saying I think SARS CO V2 very well might have come from a lab”
SARS-CoV-2 may have originated in a laboratory.
The modal phrase “very well might” does not specify a probability threshold, so it is not a well-posed factual claim that can be confirmed or refuted. WHO’s 2025 assessment says the laboratory-related hypothesis cannot be ruled out or proven, while available scientific data currently best support zoonotic origin.
Sources
- 1Independent assessment of the origins of SARS-CoV-2↗
Background
It can therefore not be ruled out, nor can it be proven until more information is provided.
- 2Independent assessment of the origins of SARS-CoV-2↗
Background
To conclude, while a zoonotic origin with spillover from animals to humans is currently considered the best supported hypothesis by the available scientific data, until requests for further information are met or more scientific data becomes available, the origins of SARS-CoV-2 and how it entered the human population will remain inconclusive.
- 1Independent assessment of the origins of SARS-CoV-2↗
-
Claim 53
“the pandemic was a collective trauma that we all went through.”
The COVID-19 pandemic was a collective trauma experienced by everyone.
Peer-reviewed reviews describe the COVID-19 pandemic and associated measures as a form of collective trauma and document widespread psychological distress. The statement does not claim that every person experienced a diagnosable trauma disorder.
The intensifier "we all" is judged as referring to a shared societal event, not the claim that every individual developed clinical trauma.
Sources
- 1The COVID-19 pandemic as a traumatic event and the associated psychological impact on families – A systematic review↗
Supports
Further, some authors refer to the COVID-19 pandemic and its measures as a “collective trauma”, defined as the psychological response of an entire group to a traumatic event, such as the Holocaust (Watson et al., 2020).
- 1The COVID-19 pandemic as a traumatic event and the associated psychological impact on families – A systematic review↗
-
Claim 54
“Republican Senators Ran Paul and Ron Johnson released text messages from Dr. Fouchy”
Republican Senators Rand Paul and Ron Johnson released text messages from Anthony Fauci.
On August 16, 2026, Senators Ron Johnson and Rand Paul announced the release of text messages obtained from Anthony Fauci’s government-issued cellphone.
Checked twice, independently: the first pass returned Accurate and the second False. Recorded as Unverifiable.
Sources
- 1Senators Johnson, Paul Release Additional Texts from Dr. Fauci’s Government iPhone↗
Supports
Today, U.S. Sen. Ron Johnson (R-Wis.), chairman of the Permanent Subcommittee on Investigations, and U.S. Sen. Rand Paul (R-Ky.), chairman of the Homeland Security and Governmental Affairs Committee, released new text messages obtained from Dr. Anthony Fauci’s government-issued cellphone which was produced by the Department of Health and Human Services (HHS) on August 5, 2026, in response to Chairman Johnson’s request.
- 1Senators Johnson, Paul Release Additional Texts from Dr. Fauci’s Government iPhone↗
-
Claim 55
“The New York Post wrote a pure clickbait headline saying quote Fouchi privately warned of miscarriage risk linked to COVID vaccine while publicly claiming no issue.”
The New York Post published a headline saying that Fauci privately warned of a miscarriage risk linked to COVID vaccination while publicly claiming there was no issue.
The quoted wording matches the headline published by the New York Post, aside from the transcript’s transcription errors in Fauci’s name and the headline’s singular/plural wording.
Sources
- 1Fauci privately warned of miscarriage risk linked to COVID vaccine while publicly claiming no issues, newly released texts show↗
Supports
Fauci privately warned of miscarriage risk linked to COVID vaccine while publicly claiming no issues, newly released texts show
- 1Fauci privately warned of miscarriage risk linked to COVID vaccine while publicly claiming no issues, newly released texts show↗
-
Claim 56
“to date there is no research suggesting a link between COVID vaccines and miscarriages”
As of the time of the statement, research did not show that COVID-19 vaccines were associated with miscarriage.
Large studies and reviews found no increased miscarriage risk after COVID-19 vaccination, so the evidence does not support a causal association. But saying there was no research suggesting a link is misleadingly absolute: early data were limited, and contemporaneous research and official discussions did consider a theoretical, unproven possibility.
Omits: The statement omits that early pregnancy-safety data were limited and that researchers and public-health officials were actively investigating a theoretical miscarriage concern; subsequent studies found no increased risk.
Checked twice, independently: the first pass returned Accurate and the second Misleading. Recorded as Misleading.
Sources
- 1Fauci discussed potential risks, benefits of COVID vaccine for pregnant women in 2021 texts released by GOP senators↗
Background
Since then, multiple studies have found no increased risk of miscarriage or other pregnancy complications after COVID-19 vaccination.
- 2Fauci texts release revives false claims linking Covid-19 vaccination, miscarriages↗
Refutes
As a result, the safety data available to Fauci and other public health officials remained limited in January 2021 when the text conversation about a theoretical, unproven risk took place.
- 3The risk of miscarriage following COVID-19 vaccination: a systematic review and meta-analysis↗
Background
Our results demonstrate no apparent increase in the risk of miscarriage among pregnant women who received the COVID-19 vaccines, which was consistent with the rate of miscarriage in the general population before the pandemic.
- 1Fauci discussed potential risks, benefits of COVID vaccine for pregnant women in 2021 texts released by GOP senators↗
-
Claim 57
“and they knew that very shortly after those texts.”
Republicans and right-wing media knew shortly after the messages were sent that research did not suggest a link between COVID vaccines and miscarriage.
The pronoun "they" is undefined and the statement does not specify what information was known, by which people, or what evidence establishes their knowledge shortly after the January 2021 messages. The available records show later safety findings, but do not establish the asserted knowledge of all Republicans or right-wing media.
Sources
- 1Senators Johnson, Paul Release Additional Texts from Dr. Fauci’s Government iPhone↗
Background
Based on the information reviewed by the Subcommittee to date, it is unclear why Dr. Mascola sends this message or what “initial studies” he is referring to.
- 2COVID-19 Vaccination for Women Who Are Pregnant or Breastfeeding↗
Background
Studies have shown no increased risk for complications like miscarriage, preterm delivery, stillbirth, or birth defects.
- 1Senators Johnson, Paul Release Additional Texts from Dr. Fauci’s Government iPhone↗
-
Claim 58
“There is evidence that it does not cause mis miscarriages. There's actually positive evidence much bigger.”
Evidence indicates that COVID-19 vaccination does not increase the risk of miscarriage.
The claim is supported in the ordinary evidence-based sense that vaccination has not been shown to cause or increase miscarriage risk. CDC guidance says studies have found no increased risk of miscarriage, and large registry studies reached the same conclusion.
Sources
- 1COVID-19 Vaccination for Women Who Are Pregnant or Breastfeeding↗
Supports
Studies have shown no increased risk for complications like miscarriage, preterm delivery, stillbirth, or birth defects.
- 2Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage↗
Supports
The results were similar in an analysis that included all available vaccine types (Table S5), in an analysis stratified according to the number of doses received (one or two), and in sensitivity analyses limited to health care personnel (for whom vaccination was routinely recommended other than in the first trimester) or women with at least 8 weeks of follow-up after confirmed pregnancy (to exclude subsequent pregnancy loss).
- 1COVID-19 Vaccination for Women Who Are Pregnant or Breastfeeding↗
-
Claim 59
“The vaccine does not cause miscarriage and co itself is a risk to pregnant women.”
COVID-19 infection poses increased health and pregnancy risks for pregnant women.
Pregnancy is associated with increased risk of severe COVID-19, and COVID-19 infection during pregnancy is associated with adverse outcomes including preterm birth and stillbirth. The transcript's apparent 'co' is understood as COVID based on the surrounding discussion.
Sources
- 1Clinical Considerations for Special Populations↗
Supports
Pregnant and recently pregnant women (at least 6 weeks following the end of pregnancy) are at increased risk of severe illness from COVID-19.
- 2Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion↗
Supports
Pregnant persons are at risk for severe coronavirus disease 2019 (Covid-19), and infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during pregnancy is associated with increased risks of preterm birth and other adverse maternal and neonatal outcomes.
- 1Clinical Considerations for Special Populations↗
-
Claim 60
“a debunked figure that claims 82% of women who got the COVID 19 vaccine during the first trimester suffered from suffer from miscarriages”
The claim that 82% of women vaccinated against COVID-19 during the first trimester suffered miscarriages was a debunked miscalculation.
The 82% figure resulted from dividing miscarriages among a selectively restricted subgroup while excluding many pregnancies that had not yet reached an outcome. The underlying CDC/NEJM data reported 104 spontaneous abortions among 827 completed pregnancies, or 12.6%, and later evidence found no increased miscarriage risk from vaccination.
Sources
- 1Fact Check: Studies Do NOT Show an 81% or 82% Miscarriage Rate in Women Vaccinated Against COVID-19 in First Trimester↗
Supports
Table 4 in the study shows that the "pregnancy loss among participants with a completed pregnancy" in the V-safe Pregnancy Registry -- developed and run by the CDC -- was 104 spontaneous abortions at less than 20 weeks out of 827 completed pregnancies, which would be a 12.6% miscarriage rate, not 82%.
- 2CDC Data Thus Far Show COVID-19 Vaccination Safe During Pregnancy↗
Supports
However, this doesn’t lend any credence to the 82% figure, which is still an incorrect calculation — and is still circulating online in newer social media posts highlighting the CDC’s correction.
- 1Fact Check: Studies Do NOT Show an 81% or 82% Miscarriage Rate in Women Vaccinated Against COVID-19 in First Trimester↗
-
Claim 61
“I was one of the earliest people to say it's time to end the mask mandates in early 22 after um after the omocrron wave.”
The speaker says they were among the earliest people to call for ending mask mandates in early 2022 after the Omicron wave.
The speaker is not identified in this excerpt, and the term “one of the earliest” has no defined cutoff or comparison group. The claim therefore cannot be reliably confirmed or refuted from the available evidence.
Sources: none found for this claim.
-
Claim 62
“President Trump signed an executive order earlier this week that advocates for the MMR vaccine for children, covers MS, measles, rebella, allin-one to be separated into three different shots, spacing out the vaccinations into three separate appointments.”
President Trump signed an executive order recommending that the childhood MMR vaccine be split into three shots and that vaccinations be administered during separate medical visits.
Trump signed the order on August 10, 2026. The White House says it recommends separating the combined MMR vaccine into three single-disease shots and administering vaccines during separate medical visits.
Sources
- 1Fact Sheet: President Donald J. Trump Delivers Gold Standard Childhood Vaccine Recommendations for Americans↗
Supports
The Order recommends separating out the combined MMR vaccine into three single-disease shots and recommends administering all vaccines during separate medical visits to give parents more options regarding the timing and frequency of this vaccine administration.
- 2Why the MMR vaccine is given as one shot, and what separating it into more could mean↗
Supports
Earlier this week, President Donald Trump signed an executive order recommending that the measles, mumps and rubella (MMR) vaccine be split into three separate shots.
- 1Fact Sheet: President Donald J. Trump Delivers Gold Standard Childhood Vaccine Recommendations for Americans↗
-
Claim 63
“He also told various lies about, you know, vats full of liquid being put into children. He then admitted he had no evidence.”
Trump said that large quantities or “vats” of vaccine are pumped into children and later acknowledged that he had no evidence that the MMR vaccine was lethal.
During the August 10, 2026 signing event, Trump said that “vats” of vaccine were pumped into children. When asked whether he had evidence that the MMR vaccine was lethal, he answered “No,” acknowledging that he did not.
Sources
- 1Trump makes false claims as he signs EO urging child vaccine changes↗
Supports
TRUMP: “Large amounts of vaccine, large amounts of like vats of vaccine are currently pumped into your child’s body.”
- 2Trump makes false claims as he signs EO urging child vaccine changes↗
Background
Doctors say, and years of real-world evidence prove, that the current combination MMR vaccine is both safe and effective at protecting children from illness.
- 3CNN.com - Transcripts: Trump Signs Order To Change Child Vaccine Recommendations↗
Supports
Pressed there by a reporter, the President acknowledged that there’s not evidence that the MMR vaccine is lethal.
- 1Trump makes false claims as he signs EO urging child vaccine changes↗
-
Claim 64
“It's a 97% effective vaccine.”
The MMR vaccine is 97% effective.
CDC reports that two doses of measles vaccine are about 97% effective against measles, but the figure does not describe uniform protection against all three diseases in MMR or apply regardless of dose. The unqualified wording therefore creates a misleading impression about the vaccine's overall effectiveness.
Omits: The 97% figure applies specifically to two doses preventing measles; MMR effectiveness differs by disease, and one dose is 72% effective against mumps and 97% against rubella.
Sources
- 1Measles Vaccine Recommendations↗
Supports
Two doses of measles vaccine are 97% (range: 67% to 100%) effective at preventing measles.
- 2Measles Vaccination↗
Background
One dose of MMR vaccine is: * 93% effective against measles * 72% effective against mumps * 97% effective against rubella
- 1Measles Vaccine Recommendations↗
-
Claim 65
“there's no monovailance available, so you can't get them individually.”
Monovalent vaccines are unavailable, so measles, mumps, and rubella cannot be obtained individually.
CDC says single-antigen measles vaccine is not available in the United States, supporting the claim in that jurisdiction. However, WHO documents monovalent measles and rubella vaccines as available options, so the unqualified statement gives a misleading global impression.
Omits: The statement omits the jurisdiction: monovalent measles vaccine is unavailable in the United States, but WHO states that monovalent measles and monovalent rubella vaccines are available internationally.
Judged as a general, worldwide claim because the speaker gives no geographic qualifier; it would be true when limited to the United States for monovalent measles vaccine.
Checked twice, independently: the first pass returned False and the second Misleading. Recorded as Misleading.
Sources
- 1Chapter 7: Measles↗
Background
Monovalent measles vaccine is not available in the United States.
- 2World Health Organization: Recommended measles and rubella vaccines↗
Refutes
Measles and rubella vaccines are available as monovalent measles and monovalent rubella, or in combination, as measles–rubella (MR), measles–mumps–rubella (MMR), and measles–mumps–rubella–varicella (MMRV) vaccine.
- 1Chapter 7: Measles↗